Clinical Insight on Semaglutide for Chronic Weight Management in Adults: Patient Selection and Special Considerations
Sign Up to like & getrecommendations! Published in 2022 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s365416
Abstract: Abstract Losses of 5–10% or more of initial body weight are associated with improvements in obesity-related comorbidities. However, attaining and sustaining this level of weight loss is challenging. The novel anti-obesity medication semaglutide 2.4 mg… read more here.
Keywords: insight semaglutide; semaglutide chronic; clinical insight; management ... See more keywords